Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 21,792 $ 27,615
Short-term investments, at amortized cost 9,943 9,874
Accounts receivable, net 2,678 2,665
Inventory, net 9,808 9,303
Prepaid expenses and other current assets 1,764 1,723
Total current assets 45,985 51,180
Property and equipment, net 949 806
Operating lease, right-of-use assets 1,762 1,895
Software license inventory 450 450
Licensing rights 970 1,028
Other assets 131 131
Total assets 50,247 55,490
Current liabilities:    
Accounts payable 1,352 272
Accrued compensation 1,454 2,824
Other accrued liabilities 1,396 2,065
Operating lease liabilities, current portion 571 561
Deferred product and service revenue, current portion 1,281 1,066
Total current liabilities 6,054 6,788
Operating lease liabilities, net of current portion 1,386 1,532
Deferred product and service revenue, net of current portion 320 390
2020 senior secured convertible note payable, net 9,907 9,893
Total liabilities 17,667 18,603
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.01 par value; 25,000,000 shares authorized; none issued and outstanding at March 31, 2023 and December 31, 2022 0 0
Common stock, $0.01 par value; 200,000,000 shares authorized; 24,582,251 shares issued and outstanding at March 31, 2023; and 24,578,983 issued and outstanding at December 31, 2022 246 246
Additional paid-in capital 188,310 187,008
Accumulated deficit (155,976) (150,367)
Total stockholders’ equity 32,580 36,887
Total liabilities and stockholders’ equity $ 50,247 $ 55,490